Elevated resting heart rate is an independent predictor of all-cause death and cardiovascular events in Japanese ambulatory hemodialysis patients

Clinical and Experimental Nephrology

Volumn 16, Issue 6, 2012, Pages 938-944

  Inoue, Taku ^a   Tokuyama, Kiyoyuki ^b   Yoshi, Shinichiro ^c   Nagayoshi, Naoko ^a   Iseki, Chiho ^a   Iseki, Kunitoshi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^b Tokuyama Clinic   (Japan)

^c Yoshi Clinic   (Japan)

Author keywords

Cardiovascular event; Heart rate; Hemodialysis; Mortality

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PREDICTION; PROSPECTIVE STUDY; RESTING HEART RATE; RISK ASSESSMENT; SURVIVAL RATE;

AGED; AMBULATORY CARE; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; REST; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 84876285471     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0641-3     Document Type: Article

References (31)

1. Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J. 1985;109(4):876-85.
2. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A. Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension. 2001;37(5):1256-61.
3. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes. 2003;111(4):215-22.
4. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26(10):967-74.
5. Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, et al. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135,164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552-60.
6. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 1996;27(2):270-6.
7. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med. 1999;159(6):585-92.
8. Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ. 2009;338:b219.
9. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J. 2007;28(24):3012-9.
10. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9641):807-16.
11. Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol. 2009;13(5):487-93.
12. Bohm M, Reil JC, Danchin N, Thoenes M, Bramlage P, Volpe M. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens. 2008;26(1):18-25.
13. Iseki K, Nakai S, Yamagata K, Tsubakihara Y. Tachycardia as a predictor of poor survival in chronic haemodialysis patients. Nephrol Dial Transplant. 2011;26(3):963-9.
14. Cice G, Di Benedetto A, D'Andrea A, D'Isa S, De Gregorio P, Marcelli D, et al. Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients. J Nephrol. 2008;21(5):704-12.
15. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron. 1982;31(2):103-10.
16. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14(8):1956-60.
17. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, et al. Heart rate as marker of sympathetic activity. J Hypertens. 1998;16(11):1635-9.
18. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34(4 Pt 2):724-8.
19. Bonaa KH, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Tromso Study. Circulation. 1992;86(2):394-405.
20. de Rooij SR, Nijpels G, Nilsson PM, Nolan JJ, Gabriel R, Bobbioni-Harsch E, et al. Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile. Diabetes Care. 2009;32(7):1295-301.
21. Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens. 2009;22(2):151-5.
22. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15(1):3-17.
23. Inoue T, Oshiro S, Iseki K, Tozawa M, Touma T, Ikemiya Y, et al. High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J. 2001;65(11):969-73.
24. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2004;25(5):363-70.
25. Inoue T, Iseki K, Iseki C, Kinjo K. Elevated resting heart rate is associated with white blood cell count in middle-aged and elderly individuals without apparent cardiovascular disease. Angiology. 2011 (Epub ahead of print).
26. Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, et al. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009;131(3):370-7.
27. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105(11):1354-9.
28. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002;62(5):1784-90.
29. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol. 2003;41(9):1438-44.
30. Iseki K, Shoji T, Nakai S, Watanabe Y, Akiba T, Tsubakihara Y. Higher survival rates of chronic hemodialysis patients on anti-hypertensive drugs. Nephron Clin Pract. 2009;113(3):c183-90.
31. Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney Int. 2006;70(11):1905-13.